New York State Common Retirement Fund decreased its holdings in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 2.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 67,835 shares of the company's stock after selling 1,733 shares during the quarter. New York State Common Retirement Fund owned approximately 0.13% of Molina Healthcare worth $22,344,000 at the end of the most recent reporting period.
Several other institutional investors also recently modified their holdings of MOH. Raymond James Financial Inc. bought a new stake in Molina Healthcare during the fourth quarter valued at $10,725,000. PNC Financial Services Group Inc. boosted its position in Molina Healthcare by 10.0% during the fourth quarter. PNC Financial Services Group Inc. now owns 3,301 shares of the company's stock valued at $961,000 after acquiring an additional 301 shares during the last quarter. Sequoia Financial Advisors LLC boosted its position in Molina Healthcare by 28.2% during the fourth quarter. Sequoia Financial Advisors LLC now owns 1,532 shares of the company's stock valued at $446,000 after acquiring an additional 337 shares during the last quarter. EverSource Wealth Advisors LLC boosted its position in Molina Healthcare by 81.5% during the fourth quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock valued at $57,000 after acquiring an additional 88 shares during the last quarter. Finally, Avantax Advisory Services Inc. boosted its position in Molina Healthcare by 7.6% during the fourth quarter. Avantax Advisory Services Inc. now owns 1,416 shares of the company's stock valued at $412,000 after acquiring an additional 100 shares during the last quarter. Institutional investors own 98.50% of the company's stock.
Molina Healthcare Stock Down 5.2%
NYSE MOH traded down $11.22 during trading hours on Thursday, hitting $204.84. The company's stock had a trading volume of 1,054,284 shares, compared to its average volume of 724,290. Molina Healthcare, Inc has a 52 week low of $201.17 and a 52 week high of $365.23. The company has a market capitalization of $11.10 billion, a PE ratio of 9.88, a price-to-earnings-growth ratio of 0.90 and a beta of 0.55. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.87. The company's 50-day simple moving average is $287.00 and its two-hundred day simple moving average is $301.64.
Molina Healthcare (NYSE:MOH - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, beating the consensus estimate of $5.96 by $0.12. The firm had revenue of $11.15 billion during the quarter, compared to analyst estimates of $10.86 billion. Molina Healthcare had a net margin of 2.81% and a return on equity of 28.38%. The company's revenue for the quarter was up 12.2% on a year-over-year basis. During the same quarter last year, the business posted $5.73 EPS. Research analysts anticipate that Molina Healthcare, Inc will post 24.4 EPS for the current fiscal year.
Insider Activity
In other Molina Healthcare news, Director Richard M. Schapiro sold 669 shares of the stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total value of $214,414.50. Following the completion of the sale, the director owned 11,244 shares in the company, valued at approximately $3,603,702. This trade represents a 5.62% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the firm's stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the sale, the chief executive officer owned 257,715 shares of the company's stock, valued at approximately $82,484,262.90. The trade was a 25.35% decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.10% of the company's stock.
Analysts Set New Price Targets
MOH has been the topic of a number of research analyst reports. Baird R W cut shares of Molina Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Barclays cut their price objective on shares of Molina Healthcare from $351.00 to $347.00 and set an "equal weight" rating on the stock in a research report on Monday, June 9th. Guggenheim initiated coverage on shares of Molina Healthcare in a research report on Wednesday, April 9th. They set a "neutral" rating on the stock. Truist Financial cut their price objective on shares of Molina Healthcare from $400.00 to $335.00 and set a "buy" rating on the stock in a research report on Wednesday. Finally, Mizuho set a $330.00 price objective on shares of Molina Healthcare and gave the stock an "outperform" rating in a research report on Friday, July 11th. Eleven equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, Molina Healthcare has an average rating of "Hold" and an average target price of $347.57.
Check Out Our Latest Analysis on Molina Healthcare
Molina Healthcare Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Read More

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.